Vaccine for cytomegalovirus
US4689225A · kind A · utility
24Cited by
3References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 2, 1984 |
| Grant date | Aug 25, 1987 |
| Priority date | — |
| Expiry date | Nov 2, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/948
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel subunit vaccine employing glycoprotein A of human cytomegalovirus or fragments thereof is provided. The vaccine is particularly suitable for inoculation of immunosuppressed individuals and women of childbearing age to inhibit the transmission of hCMV to the fetus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.